Citizens National Bank Trust Department’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-305
Closed -$1.83K 383
2026
Q1
$1.83K Buy
+305
New +$2.29K ﹤0.01% 367
2025
Q1
Sell
-2,370
Closed -$35.4K 406
2024
Q4
$35.4K Hold
2,370
0.01% 245
2024
Q3
$45.3K Hold
2,370
0.01% 224
2024
Q2
$49.1K Hold
2,370
0.01% 219
2024
Q1
$44.6K Sell
2,370
-3
-0.1% -$51 0.01% 224
2023
Q4
$34.2K Hold
2,373
0.01% 228
2023
Q3
$41.2K Hold
2,373
0.01% 214
2023
Q2
$49.4K Sell
2,373
-180
-7% -$3.91K 0.01% 209
2023
Q1
$60K Hold
2,553
0.02% 195
2022
Q4
$71K Hold
2,553
0.02% 187
2022
Q3
$60K Hold
2,553
0.02% 190
2022
Q2
$86K Buy
+2,553
New +$89.4K 0.02% 172
2022
Q1
Sell
-456
Closed -$14K 312
2021
Q4
$14K Buy
+456
New +$14.9K 0.01% 255

Other funds holding OGN

Citizens National Bank Trust Department's OGN Position: Q2 2026 in Review

Citizens National Bank Trust Department sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 305 shares — an estimated $1.83K sold.

Citizens National Bank Trust Department first reported a position in OGN in Q4 2021 and held it in 13 quarters. The position peaked at $86K in Q2 2022. 330 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Citizens National Bank Trust Department reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Citizens National Bank Trust Department sold 305 Organon & Co shares in Q2 2026, an estimated $1.83K.
  • Citizens National Bank Trust Department first reported a position in Organon & Co in Q4 2021 and held it in 13 quarters.
  • Citizens National Bank Trust Department's Organon & Co position peaked at $86K in Q2 2022.
  • 330 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.